CytomX Therapeutics, Inc. - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi CTMX

Tandha merek CytomX Pharma (CTMX)

CytomX Therapeutics (CTMX) develops "smart" Probody antibodies that activate strictly within tumors to protect healthy tissues. The GURU.Markets chart shows a pivot in absolute operating profit, driven by global corporate demand for targeted therapy and the protection of patents against dumping. The current status is 0.00, confirming that price action depends on the results of clinical trials with pharma behemoths.

CTMX: Bathi sadurunge mbayar bunga, pajak, lan amortisasi CytomX Corp 23.11.2025 - 10.11.2026

CytomX Therapeutics, Inc. - rincian analitis lan metrik utama (CTMX)

- nilai pasar lan prakiraan target analis:
Rega bursa CytomX Corp|CTMX - Target konsensus
- rincian nilai pasar emiten:
Nilai pasar CytomX Therapeutics|CTMX - Nilai Total Perusahaan
- informasi kapitalisasi buku:
Nilai Buku Saham CytomX Therapeutics|CTMX - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku cytomx.com|CTMX - Total Aset Perusahaan
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal CytomX Therapeutics|CTMX - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal CytomX Pharma|CTMX - Gunggung utang perusahaan|Rasio utang-utang marang kapitalisasi buku CytomX Therapeutics|CTMX - Utang jangka dawa perusahaan|Utang jangka cendhak CytomX Therapeutics|Rasio jangkoan perantara cytomx.com
- informasi bathi lan kelipatan valuasi:
CTMX - Bathi resik perusahaan|Bathi mangsa ngarep CytomX Therapeutics|CTMX - Rasio rega marang bathi|Kapitalisasi marang proyeksi bathi cytomx.com|CTMX - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan CytomX Therapeutics|CTMX - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan CytomX Therapeutics|CTMX - Bathi resik saben saham sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan cytomx.com|CTMX - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep CytomX Therapeutics
Ringkesan analitik perusahaan:CytomX Corp, CTMX
Produk asli cytomx.com

For the biotech sector company CytomX Therapeutics (CTMX), where capitalization depends on the versatility of drug activation platforms, this indicator serves as a measure of intellectual property monetization efficiency between quarterly reports. An analysis of EBITDA allows for the tracking of daily cash flow from core operations, where any sharp deviations in the curve signal risks of asset value drawdown.

Pesaing CytomX Therapeutics (CTMX)

Geron Bio (GERN) - Bathi sadurunge bunga, pajak, lan amortisasi|NBTX: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi BCYC (bicycletherapeutics.com)|perspectivetherapeutics.com (CATX) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi GNLX (Genelux)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Molecular Partners AG|Bathi sadurunge mbayar bunga, pajak, lan amortisasi ONCY|Bathi operasional EBITDA LSTA|Bathi operasional EBITDA moleculin.com (MBRX)|Galera Therapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi MTEM (Molecular Templates Inc)